{
  "actions": [
    {
      "acted_at": "2019-04-29", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-04-29", 
      "action_code": "", 
      "committees": [
        "SSJU"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on the Judiciary.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1224-116", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Judiciary", 
      "committee_id": "SSJU"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "G000386", 
      "district": null, 
      "name": "Grassley, Chuck", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-04-29", 
      "state": "IA", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-04-29", 
  "number": "1224", 
  "official_title": "A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr2374-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act", 
  "sponsor": {
    "bioguide_id": "K000367", 
    "district": null, 
    "name": "Klobuchar, Amy", 
    "state": "MN", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-04-29", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Stop STALLING Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Stop STALLING Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Stop STALLING Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-05-16T18:16:13Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s1224.xml"
}